// App-Quantinova.ai

5133 : Markers of Hypercoagulability in Breast Cancer: What Is Their Clinical Relevance?

Researchers

Presenter

  • Grigoris T Gerotziafas

Principal Investigators

  • Ines Ayadi

  • Jamel Daoud

  • Choumous Kallel

  • Barry J Woodhams

  • Ismail Elalamy

  • Vassiliki Galea

  • Lilia Ghorbal

  • Patrick Van Dreden

  • Diane L Rossi

  • Aurelie Rousseau

  • Racem Bouzguenda

  • Mounir Frikha

Medical Centers

  • R& Service de carcinologie, Hopital universitaire Habib Bourguiba, Sfax, Tunisia

  • R& Service de carcinologie, Hopital universitaire Habib Bourguiba, Sfax, Tunisia

  • Diagnostica Stago, Gennevilliers, France

  • Service -Hematologie Biologique, Hopital Tenon Assistance Publique Hopitaux de Paris, France, Paris, France

  • R& Gennevilliers, France, R& Service -Hematologie Biologique, Hopital Tenon, Assistance Publique Hopitaux de Paris, Paris, France,

  • Service -Hematologie Biologique, Hopital Tenon Assistance Publique Hopitaux de Paris, France, Paris, France

  • Service -Hematologie Biologique, Hopital Tenon Assistance Publique Hopitaux de Paris, France, Paris, France

  • Laboratoire -hematologie, Hopital universitaire Habib Bourguiba, Sfax, Tunisia

Locations

  • France

  • Tunisia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Catalase

Drug/Treatment

  • Phosphatidylserine

  • Fluorescein sodium

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved